Browsing by Author "Obrenovic, Radmila (56199010700)"
Now showing 1 - 9 of 9
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Atherogenic impact of homocysteine: Can hmg-coa reductase inhibitors additionally influence hyperhomocysteinaemia?; [Aterogeni potencijal homocisteina: Da li inhibitori hmg-coa reduktaze mogu uticati i na hiperhomocisteinemiju?](2019) ;Nikolic, Tamara (56425849500) ;Srejovic, Ivan (55754581700) ;Stojic, Isidora (55696426400) ;Jeremic, Jovana (56728450400) ;Folic, Marko (35098654700) ;Matic, Stevan (57201446596) ;Rakocevic, Milena (57216575040) ;Jancic, Snezana (18434143700) ;Jakovljevic, Biljana (57191337771) ;Obrenovic, Radmila (56199010700) ;Djuric, Dusan (35589783700)Zivkovic, Vladimir (55352337400)The strong association among the risk of coronary artery diseases (CAD), high levels of LDL-C and low levels of HDL-C is well established. Hyperhomocysteinaemia (HHcy) is an independent risk factor for cardiovascular disease (CVD) and causes endothelial dysfunction, a hallmark of atherosclerosis. In this study, we ascertained the influence of statins on the atherogenic index, as an indicator and a significant adjunct for predicting atherosclerosis in hyperhomocysteinaemic male Wistar albino rats. For 4 weeks, the animals were fed with one of the following diets (Mucedola SRL., Milan, Italy): standard rodent chow; a diet enriched in methionine with no deficiency in B vitamins or a diet enriched in methionine and deficient in B vitamins. The animals were simultaneously exposed to a pharmacology treatment with atorvastatin at dose of 3 mg/kg/day i.p. or simvastatin, at dose of 5 mg/kg/day i.p. We measured weight gain, food intake, and FER and determined the concentrations of biochemical parameters of dyslipidaemia (TC, TGs, LDL-C, VLDL-C, and HDL-C), AI, and CRR. A histopathological examination was conducted on portions of the right and left liver lobes from each animal. A connection between Hhcy and dyslipidaemia was indicated by the findings of biochemical and histological analyses, suggesting that Hhcy was a pro-atherogenic state. An improvement in the lipid profile along with a decrease in the atherogenic index by statins suggests that atorvastatin and simvastatin could be useful antiatherogenic agents, with protective activities during hyperhomocysteinaemia. © 2019, University of Kragujevac, Faculty of Science. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis(2009) ;Dujmovic, Irena (6701590899) ;Pekmezovic, Tatjana (7003989932) ;Obrenovic, Radmila (56199010700) ;Nikolić, Aleksandra (7005932022) ;Spasic, Mihailo (7003503254) ;Stojkovic, Marija Mostarica (6701741422)Drulovic, Jelena (55886929900)Background: Peroxynitrite was hypothesized to be involved in the pathogenesis of multiple sclerosis (MS) through its various neurotoxic effects. Uric acid (UA) was shown to be a strong peroxynitrite scavenger. Methods: We analyzed cerebrospinal fluid (CSF) and serum UA concentrations in 30 MS patients and 20 controls with non-inflammatory neurological diseases (NIND) and correlated these findings with demographic and clinical characteristics of MS patients. Disease activity was assessed by brain magnetic resonance imaging (MRI) and the CSF/serum albumin quotient as an indicator of the state of blood-brain-barrier (BBB). Results: Serum UA concentrations were found to be significantly lower in MS patients compared with controls (p=0.019). CSF UA concentrations were lower in MS patients as compared to controls, as well as in patients with active MS (clinical and/or MRI activity) in comparison to patients with inactive MS or controls, but these differences were not statistically significant. Significant correlation was found between CSF and serum UA concentrations (p=0.016) in MS patients, but not in controls; and between CSF UA concentrations and the CSF/serum albumin quotient in MS patients (p=0.043), but not in controls. Conclusions: Our results support the significance of UA in the pathogenesis of MS. Decreased serum UA concentrations in MS patients might be due to both intrinsically reduced antioxidant capacity and increased UA consumption in MS. CSF UA concentrations may not be a reliable marker of disease activity in MS since its concentration is dependent on leakage of UA molecules from serum through the damaged BBB and the balance between consumption/ production within the central nervous system (CNS). © 2009 by Walter de Gruyter Berlin New York. - Some of the metrics are blocked by yourconsent settings
Publication Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis(2009) ;Dujmovic, Irena (6701590899) ;Pekmezovic, Tatjana (7003989932) ;Obrenovic, Radmila (56199010700) ;Nikolić, Aleksandra (7005932022) ;Spasic, Mihailo (7003503254) ;Stojkovic, Marija Mostarica (6701741422)Drulovic, Jelena (55886929900)Background: Peroxynitrite was hypothesized to be involved in the pathogenesis of multiple sclerosis (MS) through its various neurotoxic effects. Uric acid (UA) was shown to be a strong peroxynitrite scavenger. Methods: We analyzed cerebrospinal fluid (CSF) and serum UA concentrations in 30 MS patients and 20 controls with non-inflammatory neurological diseases (NIND) and correlated these findings with demographic and clinical characteristics of MS patients. Disease activity was assessed by brain magnetic resonance imaging (MRI) and the CSF/serum albumin quotient as an indicator of the state of blood-brain-barrier (BBB). Results: Serum UA concentrations were found to be significantly lower in MS patients compared with controls (p=0.019). CSF UA concentrations were lower in MS patients as compared to controls, as well as in patients with active MS (clinical and/or MRI activity) in comparison to patients with inactive MS or controls, but these differences were not statistically significant. Significant correlation was found between CSF and serum UA concentrations (p=0.016) in MS patients, but not in controls; and between CSF UA concentrations and the CSF/serum albumin quotient in MS patients (p=0.043), but not in controls. Conclusions: Our results support the significance of UA in the pathogenesis of MS. Decreased serum UA concentrations in MS patients might be due to both intrinsically reduced antioxidant capacity and increased UA consumption in MS. CSF UA concentrations may not be a reliable marker of disease activity in MS since its concentration is dependent on leakage of UA molecules from serum through the damaged BBB and the balance between consumption/ production within the central nervous system (CNS). © 2009 by Walter de Gruyter Berlin New York. - Some of the metrics are blocked by yourconsent settings
Publication The clinical importance of cystatin C and hepatic artery resistive index in liver cirrhosis(2018) ;Stulic, Milos (55895099100) ;Culafic, Djordje (6603664463) ;Obrenovic, Radmila (56199010700) ;Jankovic, Goran (7005387171) ;Alempijevic, Tamara (15126707900) ;Lalosevic, Milica Stojkovic (57218133245) ;Dostanic, Natasa (57203871434) ;Kovacevic, Sandra Vezmar (57204567668)Culafic, Milica (55881915300)Background: Data suggest cystatin C (CysC) levels and hepatic artery resistive index (HARI) correspond to the progression of chronic liver disease. We aimed to evaluate the clinical significance of these parameters in assessment of fibrosis in patients with liver cirrhosis. Methods: The cross-sectional study included 63 patients with liver cirrhosis. A control group consisted of 30 age-and gender-matched healthy persons. Results: We confirmed significantly higher values of CysC in patients with cirrhosis compared to control group (p = 0.036). Average value of HARI in the examined group was increased (0.72 ± 0.06) and there was the statistically significant difference compared to controls (0.66 ± 0.03) (p < 0.001). We found statistically significant correlation between HARI and CysC in the study group. Analyzing the possibility of distinguishing healthy subjects from patients with fibrosis, we have found that the area under the curve is far greater in the HARI index than CysC. Comparison of CysC among Child–Pugh stages and correlation with a model for end-stage liver disease (MELD) score showed statistically significant results. Conclusion: We confirmed HARI is a more accurate parameter than CysC in discriminating healthy subjects from patients with fibrosis, while CysC could be a better indicator of the stage of liver cirrhosis. © 2018 by the authors. Licensee MDPI, Basel, Switzerland. - Some of the metrics are blocked by yourconsent settings
Publication The effects of subchronic methionine overload administered alone or simultaneously with L-Cysteine or N-AcetyL-L-Cysteine on body weight, homocysteine levels and biochemical parameters in the blood of male wistar rats; [Efekti subhroničnog opterećnja metioninom samostalno ili U kombinaciji sa L-Cisteinom ili N-Acetil-L-Cisteinom na telesnu masu, vrednosti ukupnog homocisteina I biohemijske parametre U krvi mužjaka wistar pacova](2016) ;Micovic, Zarko (57191333725) ;Stamenkovic, Aleksandra (57194596358) ;Nikolic, Tamara (56425849500) ;Stojanovic, Marija (57218666738) ;Scepanovic, Ljiljana (6506067087) ;Hadzibegovic, Adi (57191339256) ;Obrenovic, Radmila (56199010700) ;Vujosevic, Ivana (57191329609) ;Stankovic, Sanja (7005216636) ;Djuric, Marko (56467826000) ;Jakovljevic, Biljana (57191337771)Djuric, Dragan (36016317400)Hyperhomocysteinemia (HHC), both basal and after methionine load, may occur due to genetic disorders or deficiencies of nutrients that affect the remethylation or transsulphuration pathways during methionine metabolism. HHC is involved in the pathogenesis of many illnesses as a result of its prooxidative effect and its impairment of antioxidative protection. The aim was to examine the effects of subchronic methionine overload on the body weight and standard biochemical parameters in rat serum and to examine whether simultaneous subchronic intraperotoneal administration of methionine alone or together with L-cysteine or N-acetyl-cysteine resulted in a change in the body weight and biochemical parameters in the rat serum. The research was conducted during a three-week period (male Wistar albino rats, n=36, body weight of approximately 160 g, age of 15-20 days), and the animals were divided into a control group and three experimental groups of 8-10 animals each: a) control group (0.9% sodium chloride 0.1-0.2 ml/day); b) methionine (0.8 mmol/kg/bw/day) (MET group); c) methionine (0.8 mmol/kg/bw/day) + L-cysteine (7 mg/kg/bw/day) (L-cys+MET group); and d) methionine (0.8 mmol/kg/bw/ day) + N-acetyl-L-cysteine (50 mg/kg/bw/day) (NAC+MET group). In addition to the body weight monitoring, the levels of total homocysteine and the standard biochemical parameters in blood samples (plasma or serum) were determined. The results indicated that monitoring the homocysteine levels and standard biochemical parameters in blood could be used for analysis and could provide an excellent guideline for distinguishing between toxic and non-toxic doses of methionine intake, which may be meaningful for clinical applications. © 2016, University of Kragujevac, Faculty of Science. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication The importance of the blood levels of homocysteine, folate and vitamin B12 in patients with primary malignant brain tumors(2021) ;Djurovic, Zivanka (57221258410) ;Jovanovic, Vladimir (35925328900) ;Obrenovic, Radmila (56199010700) ;Djurovic, Branko (14518891700) ;Soldatovic, Ivan (35389846900) ;Vranic, Aleksandra (56688465900) ;Jakovljevic, Vladimir (56425747600) ;Djuric, Dragan (36016317400)Zivkovic, Vladimir (55352337400)Purpose: Glioblastoma multiforme and anaplastic astrocytoma represent one of the most frequently occurring primary brain tumors with dismal survival rates. The aim of our study was to investigate whether values of homocysteine, folates and vitamin B12 can be prognostic markers in relapse diagnosis, treatment and monitoring of adult patients with malignant brain tumors. Methods: Twenty-seven patients from the Neurosurgical Clinic, Clinical Center of Serbia with diagnosed malignant brain tumors (anaplastic astrocytoma GR III and glioblastoma multiforme GR IV), were included in the study. The patients were divided in two groups according to the progression of disease, 15 with and 12 without progression. Results: Mean values of homocysteine were significantly higher in the group with progression compared to the group without malignant tumor progression, at the baseline point and after six months. Mean values of folate were similar across groups in all measurements, except in the 3rd month after surgery. Results regarding vitamin B12 were similar to folate, without any significance in group comparisons in the examined time points, as well as in vitamin B12 values change. Conclusions: Our results pointed out that total homocysteine in blood circulation appears to be a tumor marker for monitoring primary malignant brain tumor patients before and after surgery. The association of hyperhomocysteinemia with folate deficiency, also provides strong support for viewing hyperhomocysteinemia as a predictive marker for carcinogenesis. It is hoped that future research will continue to explore the clinical relevance of homocysteine as a tumor marker and a risk factor for astrocytoma and glioblastoma. © 2020 Zerbinis Publications. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication The importance of the blood levels of homocysteine, folate and vitamin B12 in patients with primary malignant brain tumors(2021) ;Djurovic, Zivanka (57221258410) ;Jovanovic, Vladimir (35925328900) ;Obrenovic, Radmila (56199010700) ;Djurovic, Branko (14518891700) ;Soldatovic, Ivan (35389846900) ;Vranic, Aleksandra (56688465900) ;Jakovljevic, Vladimir (56425747600) ;Djuric, Dragan (36016317400)Zivkovic, Vladimir (55352337400)Purpose: Glioblastoma multiforme and anaplastic astrocytoma represent one of the most frequently occurring primary brain tumors with dismal survival rates. The aim of our study was to investigate whether values of homocysteine, folates and vitamin B12 can be prognostic markers in relapse diagnosis, treatment and monitoring of adult patients with malignant brain tumors. Methods: Twenty-seven patients from the Neurosurgical Clinic, Clinical Center of Serbia with diagnosed malignant brain tumors (anaplastic astrocytoma GR III and glioblastoma multiforme GR IV), were included in the study. The patients were divided in two groups according to the progression of disease, 15 with and 12 without progression. Results: Mean values of homocysteine were significantly higher in the group with progression compared to the group without malignant tumor progression, at the baseline point and after six months. Mean values of folate were similar across groups in all measurements, except in the 3rd month after surgery. Results regarding vitamin B12 were similar to folate, without any significance in group comparisons in the examined time points, as well as in vitamin B12 values change. Conclusions: Our results pointed out that total homocysteine in blood circulation appears to be a tumor marker for monitoring primary malignant brain tumor patients before and after surgery. The association of hyperhomocysteinemia with folate deficiency, also provides strong support for viewing hyperhomocysteinemia as a predictive marker for carcinogenesis. It is hoped that future research will continue to explore the clinical relevance of homocysteine as a tumor marker and a risk factor for astrocytoma and glioblastoma. © 2020 Zerbinis Publications. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Vitamin B complex mitigates cardiac dysfunction in high-methionine diet-induced hyperhomocysteinemia(2018) ;Jeremic, Jovana (56728450400) ;Nikolic Turnic, Tamara (56425849500) ;Zivkovic, Vladimir (55352337400) ;Jeremic, Nevena (56609154900) ;Milosavljevic, Isidora (55696426400) ;Srejovic, Ivan (55754581700) ;Obrenovic, Radmila (56199010700) ;Jancic, Snezana (18434143700) ;Rakocevic, Milena (57216575040) ;Matic, Stevan (57201446596) ;Djuric, Dragan (36016317400)Jakovljevic, Vladimir (56425747600)This research is designed to test the hypothesis that elevated homocysteine (Hcy) levels in vivo, caused by a deficit in vitamin B complex, promote changes in cardiac function and redox status that lead to heart failure. In order to conduct the study, we used adult male Wistar albino rats (n = 30; 4 weeks old; 100 ± 15 g body weight). Hyperhomocysteinaemia (HHcy) in these animals was achieved by dietary manipulation. For 4 weeks, the animals were fed with a standard rodent chow (control, CF), a diet enriched in methionine with no deficiency in B vitamins (i.e., folic acid, B6 and B12) (HMNV) or a diet enriched in methionine and deficient in B vitamins (HMLV). After 28 days of dietary manipulation, all animals were killed. The rat hearts were isolated and retrogradely perfused according to the Langendorff technique at a gradually increasing perfusion pressure. We found a negative correlation between elevated serum Hcy and total body and heart weight. The maximum rate of left ventricular pressure development was significantly increased in the HMNV group compared with in the other groups. Systolic left ventricular pressure was significantly changed in all groups. HHcy induces remodelling of the cardiac tissues, as moderate HHcy is associated with more prominent interstitial and perivascular fibrosis. Our results suggest that a high methionine diet without vitamin B complex causes profound negative effects associated with HHcy. © 2018 John Wiley & Sons Australia, Ltd - Some of the metrics are blocked by yourconsent settings
Publication Vitamin B complex mitigates cardiac dysfunction in high-methionine diet-induced hyperhomocysteinemia(2018) ;Jeremic, Jovana (56728450400) ;Nikolic Turnic, Tamara (56425849500) ;Zivkovic, Vladimir (55352337400) ;Jeremic, Nevena (56609154900) ;Milosavljevic, Isidora (55696426400) ;Srejovic, Ivan (55754581700) ;Obrenovic, Radmila (56199010700) ;Jancic, Snezana (18434143700) ;Rakocevic, Milena (57216575040) ;Matic, Stevan (57201446596) ;Djuric, Dragan (36016317400)Jakovljevic, Vladimir (56425747600)This research is designed to test the hypothesis that elevated homocysteine (Hcy) levels in vivo, caused by a deficit in vitamin B complex, promote changes in cardiac function and redox status that lead to heart failure. In order to conduct the study, we used adult male Wistar albino rats (n = 30; 4 weeks old; 100 ± 15 g body weight). Hyperhomocysteinaemia (HHcy) in these animals was achieved by dietary manipulation. For 4 weeks, the animals were fed with a standard rodent chow (control, CF), a diet enriched in methionine with no deficiency in B vitamins (i.e., folic acid, B6 and B12) (HMNV) or a diet enriched in methionine and deficient in B vitamins (HMLV). After 28 days of dietary manipulation, all animals were killed. The rat hearts were isolated and retrogradely perfused according to the Langendorff technique at a gradually increasing perfusion pressure. We found a negative correlation between elevated serum Hcy and total body and heart weight. The maximum rate of left ventricular pressure development was significantly increased in the HMNV group compared with in the other groups. Systolic left ventricular pressure was significantly changed in all groups. HHcy induces remodelling of the cardiac tissues, as moderate HHcy is associated with more prominent interstitial and perivascular fibrosis. Our results suggest that a high methionine diet without vitamin B complex causes profound negative effects associated with HHcy. © 2018 John Wiley & Sons Australia, Ltd
